Accéder au contenu
Merck

Effects of WT1 down-regulation on oocyte maturation and preimplantation embryo development in pigs.

Reproduction (Cambridge, England) (2014-07-18)
Fei Gao, Jiyu Guan, Limei Liu, Sheng Zhang, Peipei An, Anran Fan, Guangqi Song, Peng Zhang, Tianchuang Zhao, Bo Tang, Xueming Zhang, Ziyi Li
RÉSUMÉ

The Wilms' tumour 1 (WT1) gene originally identified as a tumour suppressor associated with WTs encodes a zinc finger-containing transcription factor that is expressed in multiple tissues and is an important regulator of cellular and organ growth, proliferation, development, migration and survival. However, there is a deficiency of data regarding the expression and function of WT1 during oocyte maturation and preimplantation embryonic development. Herein, we sought to define the expression characteristics and functions of WT1 during oocyte maturation and preimplantation embryonic development in pigs. We show that WT1 is expressed in porcine oocytes and at all preimplantation stages in embryos generated by ICSI. We then evaluated the effects of down-regulating WT1 expression at germinal vesicle and early ICSI stages using a recombinant plasmid (pGLV3-WT1-shRNA). Down-regulation of WT1 did not affect oocyte maturation but significantly decreased preimplantation embryonic development and increased apoptosis in blastocysts. These results indicate that WT1 plays important roles in the development of porcine preimplantation embryos.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Kit de détection in situ de mort cellulaire avec POD, sufficient for ≤50 tests
Sigma-Aldrich
Anticorps de chèvre anti-IgG de lapin (chaînes lourdes et légères), conjugué au FITC, Upstate®, from goat
Sigma-Aldrich
Anticorps de chèvre anti-IgG de lapin (chaînes H+L), conjugué à la rhodamine, 1.0 mg/mL, Chemicon®
Sigma-Aldrich
MISSION® esiRNA, targeting human WT1